Browsing Tag
Schizophrenia
20 posts
Teva Pharmaceuticals, MedinCell get UZEDY FDA approval for schizophrenia
Teva Pharmaceuticals and MedinCell have bagged approval for UZEDY (risperidone) extended-release injectable suspension from the US Food and…
Glenmark Pharmaceuticals gets FDA final approval for Compazine generic
Glenmark Pharmaceuticals has bagged final approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg from the…
Zydus Lifesciences gets FDA final approval for Olanzapine tablets
Zydus Lifesciences said that it has secured final approval for Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10mg,…
Lupin launches schizophrenia drug Invega generic in US
Indian pharma company Lupin Limited has launched Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9…
Zydus Lifesciences bags FDA approval for Cariprazine generic
Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary — Zydus Pharmaceuticals (USA) has secured final approval…
Zydus Cadila gets FDA tentative approval for Cariprazine Capsules
Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval from the US Food and…
Unichem Laboratories gets FDA approval for Aripiprazole Tablets, USP
Unichem Laboratories said that it has secured a tentative approval for abbreviated new drug application (ANDA) of Aripiprazole…
Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets
Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food…
Novartis to acquire Cadent Therapeutics in $770m deal to bolster neuropsychiatric pipeline
Find out how Novartis plans to transform neuroscience with its $770M acquisition of Cadent Therapeutics and its novel CNS treatment pipeline.
Biogen strikes $600m deal with Pfizer for promising schizophrenia drug
Biogen, a leading US biotechnology firm, has reached a significant agreement to acquire Pfizer’s neurology drug candidate, PF-04958242,…